Bisphosphonates in multiple myeloma: an updated network meta-analysis. https://t.co/OSw5rdlZsS
RT @CochraneLibrary: #CochraneEvidence: use of bisphosphonates in participants with #multiplemyeloma reduces pathological vertebral fractur…
RT @CochraneUK: Bisphosphonates in multiple myeloma. Here’s the latest #CochraneEvidence https://t.co/Bm1GHb69qB https://t.co/z5JpqSFGxy
Bisphosphonates in multiple myeloma: an updated network meta-analysis https://t.co/NI3Xf7NKxp - Does adding bisphosphonates to standard therapy in MM improves OS and progression-free survival and also decrease skeletal-related morbidity? https://t.co/wiVJN
RT @CochraneUK: Bisphosphonates in multiple myeloma. The latest #CochraneEvidence https://t.co/xNo8s53rSr https://t.co/Qv47o6B696
RT @CochraneUK: Bisphosphonates in multiple myeloma. The latest #CochraneEvidence https://t.co/xNo8s53rSr https://t.co/Qv47o6B696
RT @CochraneUK: Bisphosphonates in multiple myeloma. The latest #CochraneEvidence https://t.co/Xc3TJbwWrO https://t.co/cO2Tx1mb00
RT @CochraneUK: Bisphosphonates in multiple myeloma. The latest #CochraneEvidence https://t.co/xNo8s53rSr https://t.co/Qv47o6B696
RT @AmadeoWals: Mieloma multiple y bifosfonatos https://t.co/MuPV3LTWNA #MMSM #MIELOMA https://t.co/hu5FP8yb8v
RT @AmadeoWals: Mieloma multiple y bifosfonatos https://t.co/MuPV3LTWNA #MMSM #MIELOMA https://t.co/hu5FP8yb8v
Mieloma multiple y bifosfonatos https://t.co/MuPV3LTWNA #MMSM #MIELOMA https://t.co/hu5FP8yb8v
RT @CochraneUK: Bisphosphonates in multiple myeloma. Here’s the latest #CochraneEvidence https://t.co/Bm1GHb69qB https://t.co/z5JpqSFGxy
RT @CochraneUK: Bisphosphonates in multiple myeloma. Here’s the latest #CochraneEvidence https://t.co/Bm1GHb69qB https://t.co/z5JpqSFGxy
RT @CochraneUK: Bisphosphonates in multiple myeloma. Here’s the latest #CochraneEvidence https://t.co/Bm1GHb69qB https://t.co/z5JpqSFGxy
RT @CochraneUK: Bisphosphonates in multiple myeloma. Here’s the latest #CochraneEvidence https://t.co/Bm1GHb69qB https://t.co/z5JpqSFGxy
RT @CochraneUK: Bisphosphonates in multiple myeloma. Here’s the latest #CochraneEvidence https://t.co/Bm1GHb69qB https://t.co/z5JpqSFGxy
#isoppnews Use of bisphosphonates in participants with MM reduces pathological vertebral fractures, SREs and pain. Bisphosphonates were associated with an increased risk of developing ONJ. https://t.co/cPaPnU5oxG
RT @CochraneLibrary: #CochraneEvidence: use of bisphosphonates in participants with #multiplemyeloma reduces pathological vertebral fractur…
RT @CochraneLibrary: #CochraneEvidence: use of bisphosphonates in participants with #multiplemyeloma reduces pathological vertebral fractur…
RT @CochraneLibrary: #CochraneEvidence: use of bisphosphonates in participants with #multiplemyeloma reduces pathological vertebral fractur…
RT @CochraneLibrary: #CochraneEvidence: use of bisphosphonates in participants with #multiplemyeloma reduces pathological vertebral fractur…
RT @CochraneLibrary: #CochraneEvidence: use of bisphosphonates in participants with #multiplemyeloma reduces pathological vertebral fractur…
#CochraneEvidence: use of bisphosphonates in participants with #multiplemyeloma reduces pathological vertebral fractures, skeletal-related events and pain. Bisphosphonates were associated with an increased risk of developing osteonecrosis of the jaw: https
Updated Cochrane Review: #Bisphosphonates in multiple #myeloma: an updated network meta-analysis https://t.co/CzfzE6OuSc
RT @Dr_HMawardi: Great paper to read. ONJ continues to be a possible complication of BP depending on type of BP, strength and duration. How…
Great paper to read. ONJ continues to be a possible complication of BP depending on type of BP, strength and duration. However, BP benefit specifically for MM patients outweighs its side effects. https://t.co/8ns01eF15L
RT @Myeloma_Doc: Updated network meta-analysis of bisphosphonates in #myeloma finds that they reduce pathological vertebral fractures, skel…
Bisphosphonates in multiple myeloma: an updated network meta-analysis. https://t.co/otBokCEOB6
RT @Myeloma_Doc: Updated network meta-analysis of bisphosphonates in #myeloma finds that they reduce pathological vertebral fractures, skel…
RT @Myeloma_Doc: Updated network meta-analysis of bisphosphonates in #myeloma finds that they reduce pathological vertebral fractures, skel…
(Cochrane) Seguridad y eficacia d los bifosfonatos en mieloma múltiple https://t.co/w9i13h6JO1
RT @Myeloma_Doc: Updated network meta-analysis of bisphosphonates in #myeloma finds that they reduce pathological vertebral fractures, skel…
RT @Myeloma_Doc: Updated network meta-analysis of bisphosphonates in #myeloma finds that they reduce pathological vertebral fractures, skel…
Updated network meta-analysis of bisphosphonates in #myeloma finds that they reduce pathological vertebral fractures, skeletal related events and pain, and #Zometa may be better for improving overall survival and other outcomes: https://t.co/OkKnwBD8EN. ht
Bisphosphonates in multiple myeloma. Here's the latest #CochraneEvidence https://t.co/e16iiP0LQ0
Bisphosphonates in multiple myeloma https://t.co/FFtSUvH8XS
Bisphosphonates in multiple myeloma: an updated network meta-analysis. https://t.co/Hf2oLz1HaT
Bisphosphonates in multiple myeloma: an updated network meta-analysis. https://t.co/OSw5rdlZsS